Germany’s €400m aid to Sanofi for insulin production wins EU clearance
( September 8, 2026, 09:46 GMT | Official Statement) -- MLex Summary: Germany has secured EU state aid clearance to give €400 million of support to drugmaker Sanofi, to cover the costs of a program designed to strengthen the resilience of its supply of insulin. The European Commission said the support would enable Sanofi to build a new insulin factory in Frankfurt, to produce at least 1.1 metric tons of insulin a year until the end of 2042, to stockpile ingredients, and to prioritize the European market in case of shortages.Statement follows....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.